Stuart McPherson

Stuart McPherson is currently serving as Associate Director, Clinical Scientist at Adaptimmune since September 2023. Prior experience includes Associate Director of Clinical Operations at BerGenBio ASA, from May 2019 to September 2023, focusing on innovative drugs for aggressive diseases, including COVID-19 and oncology. Stuart has held various positions in clinical project management, including Senior Clinical Project Manager at Bionical Emas and Senior Associate, Clinical Operations at Eisai, with a strong emphasis on Oncology and global phase III studies. Additional roles at Amgen and Boehringer Ingelheim involved global study management and extensive clinical research experience across cardiovascular and oncology trials. Stuart began a career in pharmaceuticals at PRA International as a Clinical Research Associate, following a BSc in Biotechnology from Cardiff University.